Evaluation of potential herb-drug interactions between oseltamivir and commonly used anti-influenza Chinese medicinal herbs.

Authors:
Zhang Y; Lyu C; Fong SYK; Wang Q; Li C and 4 more

Journal:
J Ethnopharmacol

Publication Year: 2019

DOI:
10.1016/j.jep.2019.112097

PMCID:
PMC7125811

PMID:
31325600

View on PubMed View on PMC View Publisher
Journal Information

Full Title: J Ethnopharmacol

Abbreviation: J Ethnopharmacol

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Social Sciences

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Related Papers from Same Journal
Comparison study of Beninese and Chinese herbal medicines in treating COVID-19.
Houeze EA; Wang Y; Zhou Q and 2 more (2023) - Transparency Score: 4/6
Chemical profiling and unraveling of anti-COVID-19 biomarkers of red sage (Lantana camara L.) culti…
Darwish RS; El-Banna AA; Ghareeb DA and 3 more (2022) - Transparency Score: 2/6
Efficacy and safety of add-on Viola odorata L. in the treatment of COVID-19: A randomized double-bl…
Adel Mehraban MS; Shirzad M; Mohammad Taghizadeh Kashani L and 5 more (2022) - Transparency Score: 4/6
Jinhua Qinggan granules attenuates acute lung injury by promotion of neutrophil apoptosis and inhib…
Zhu Y; Han Q; Wang L and 10 more (2022) - Transparency Score: 4/6
Shufeng Jiedu capsule inhibits inflammation and apoptosis by activating A2AAR and inhibiting NF-κB …
Cai J; Wang YL; Sheng XD and 2 more (2022) - Transparency Score: 3/6
View All Papers from This Journal
Transparency Score
2/6
0.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Conflicts of interest There are no conflicts of interest among the authors."

Evidence found in paper:

"This work is supported by 10.13039/501100005847Health and Medical Research Fund (Reference number: 11120451) from the 10.13039/501100005407Food and Health Bureau of the Government of the Hong Kong Special Administrative Region."

Protocol Registration
Open Access
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025